ArticleInvestigational new drugs2025
Lenvatinib plus immunotherapy versus lenvatinib monotherapy in lenvatinib-insensitive patients with unresectable hepatocellular carcinoma: a retrospective study.
Zeyu Yu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.